TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
SLS

Sellas Life Sciences Group Inc

Healthcare · Biotechnology · —

12.00$ +4.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow SLS
Line item 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – – – – – – – – – –
– – +263.9% +23.7% +6.2% -5.2% -69.9% +822.4% +96.7% -60.1% -60.0% -100.0% – -54.9% -83.4% +1,916.0% -92.0% – – –
– – – +9.9% +4.0% -31.3% -53.5% +81.5% +112.9% -64.2% +17.2% +40.0% -87.5% +45.1% +0.9% +74.9% +70.7% -19.5% +12.5% +25.1%
– – – – – – -77.1% -116.7% – -226.4% – – +17.2% -56.1% -77.3% +205.7% +416.8% – – –
– – -100.7% – +9.5% +718.9% -95.9% +2,267.0% +58.9% +398.4% -225.4% – -265.0% – – -236.2% – -40.7% -298.7% –
– – -27.5% -50.0% +27.7% -50.0% +1,294.3% +2,044.5% -65.1% -97.2% -96.1% -100.0% – – – – – +22.2% -100.0% –
– – – -100.9% +27.7% – -721.4% +13,734.5% -54.1% – -110.2% – – – +0.0% +0.0% +0.0% +22.2% – –
– – – – – -100.0% – – – – +0.0% +38.6% -27.9% -100.0% – – – – – –
– – – – – – +123.0% +9.8% -43.9% +84.2% -28.3% -98.6% +6,498.5% -37.3% +94.9% – – – – –
– – – – – – -88.1% – -117.9% +121.5% – -102.7% +1,507.0% – – – – – – –
– +744.4% -55.6% -3.1% +50.7% +65.9% +121.0% +31.8% -56.6% +80.7% -21.7% -83.9% +317.8% -15.4% +96.4% -68.6% +99.4% -7.3% +109.5% +84.6%
– -16.6% +359.6% -151.6% – +276.3% +370.6% -29.9% -261.1% – -291.6% – – – +1,355.1% -149.8% – – – +409.9%
– – – – – – – – – – – – – – – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?